These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15348998)

  • 1. Opsoclonus-myoclonus syndrome during pregnancy.
    Koide R; Sakamoto M; Tanaka K; Hayashi H
    J Neuroophthalmol; 2004 Sep; 24(3):273. PubMed ID: 15348998
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of idiopathic opsoclonus-myoclonus syndrome with intravenous immunoglobulin.
    Unal A; Sumer MM; Atasoy HT; Atasoy N
    Neurol India; 2004 Dec; 52(4):520-1. PubMed ID: 15626860
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy.
    Pranzatelli MR; Chun KY; Moxness M; Tate ED; Allison TJ
    Pediatr Neurol; 2005 Aug; 33(2):121-6. PubMed ID: 16087057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correspondence: treatment of the neuroblastoma-associated opsoclonus-myoclonus-ataxia (OMA) syndrome with high-dose methylprednisolone.
    Emir S; Akyüz C; Büyükpamukçu M
    Med Pediatr Oncol; 2003 Feb; 40(2):139. PubMed ID: 12461808
    [No Abstract]   [Full Text] [Related]  

  • 5. [Opsoclonus-myoclonus syndrome in patient with ovarian cancer].
    Rubio Nazábal E; Marey López J; Avarez Pérez P; López Facal S; Alonso Magdalena L
    An Med Interna; 2003 Jul; 20(7):370-2. PubMed ID: 12892556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of opsoclonus-myoclonus-ataxia with neuroblastoma.
    Mukherjee A; Mukherjee A; Chakrabarty S
    J Indian Med Assoc; 2004 Nov; 102(11):647-8. PubMed ID: 15868878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features--correlation of clinical improvement with tumor response.
    Erlich R; Morrison C; Kim B; Gilbert MR; Alrajab S
    Cancer Invest; 2004; 22(2):257-61. PubMed ID: 15199608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic opsoclonus-myoclonus syndrome associated with malignant fibrous histiocytoma: neuropathological findings.
    Zámecník J; Cerný R; Bartos A; Jerábek J; Bojar M
    Cesk Patol; 2004 Apr; 40(2):63-7. PubMed ID: 15233019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
    Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
    Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic results in three cases of ganglioneuroblastoma associated with opsoclonus myoclonus ataxia syndrome.
    Shtarbanov IA; Boronsuzov IK; Chakarov IR; Konstantinov DN
    Indian J Cancer; 2020; 57(2):216-218. PubMed ID: 31898588
    [No Abstract]   [Full Text] [Related]  

  • 11. Opsoclonus-myoclonus syndrome: gabapentin as a new therapeutic proposal.
    Moretti R; Torre P; Antonello RM; Nasuelli D; Cazzato G
    Eur J Neurol; 2000 Jul; 7(4):455-6. PubMed ID: 10971608
    [No Abstract]   [Full Text] [Related]  

  • 12. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
    Cooper R; Khakoo Y; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Nakagawa A; Shimada H
    Med Pediatr Oncol; 2001 Jun; 36(6):623-9. PubMed ID: 11344493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome.
    Blaes F; Fühlhuber V; Korfei M; Tschernatsch M; Behnisch W; Rostasy K; Hero B; Kaps M; Preissner KT
    Ann Neurol; 2005 Aug; 58(2):313-7. PubMed ID: 15988749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuro-ophthalmologic manifestations of paraneoplastic syndromes.
    Ko MW; Dalmau J; Galetta SL
    J Neuroophthalmol; 2008 Mar; 28(1):58-68. PubMed ID: 18347462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parainfectious opsoclonus-myoclonus syndrome: high dose intravenous immunoglobulins are effective.
    Glatz K; Meinck HM; Wildemann B
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):279-80. PubMed ID: 12531974
    [No Abstract]   [Full Text] [Related]  

  • 16. Opsoclonus-myoclonus syndrome as a paraneoplastic manifestation of renal cell carcinoma. a case report and review of the literature.
    De Luca S; Terrone C; Crivellaro S; De Zan A; Polo P; Vigliani MC; Tizzani A
    Urol Int; 2002; 68(3):206-8. PubMed ID: 11919472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: cerebellar atrophy, multiphasic relapses, and response to IVIG.
    Pranzatelli MR; Tate ED; Kinsbourne M; Caviness VS; Mishra B
    Mov Disord; 2002 Nov; 17(6):1387-90. PubMed ID: 12465092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic disorders of the central and peripheral nervous systems.
    Didelot A; Honnorat J
    Handb Clin Neurol; 2014; 121():1159-79. PubMed ID: 24365410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paraneoplastic opsoclonus-myoclonus syndrome associated with small-cell lung cancer].
    Margery J; Ferroir JP; Epaud C; Martin C; Milleron B
    Rev Pneumol Clin; 2003 Nov; 59(5 Pt 1):321-4. PubMed ID: 14707930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis.
    Armstrong MB; Robertson PL; Castle VP
    Pediatr Neurol; 2005 Nov; 33(5):365-7. PubMed ID: 16243225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.